Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: is there a link?

被引:0
|
作者
Pedersen, Susanne S. [1 ,2 ]
Brouwers, Corline [1 ]
Versteeg, Henneke [1 ]
机构
[1] Tilburg Univ, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands
[2] Erasmus MC, Thoraxctr, Dept Cardiol, Rotterdam, Netherlands
关键词
arrhythmias; distress; implantable cardioverter defibrillator; mechanisms; mortality; psychological vulnerability; T-WAVE ALTERNANS; QUALITY-OF-LIFE; SUDDEN CARDIAC DEATH; HEART-FAILURE; DEPRESSIVE SYMPTOMS; RISK STRATIFICATION; COST-EFFECTIVENESS; HEALTH BEHAVIORS; D PERSONALITY; ANXIETY;
D O I
10.1586/ERD.12.31
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Implantable cardioverter defibrillator (ICD) therapy is the first-line treatment for the prevention of sudden cardiac death. Despite the demonstrated survival benefits of the ICD, predicting which patients will die from a ventricular tachyarrhythmia remains a major challenge. So far, psychological factors have not been considered as potential risk markers that might enhance the prediction of sudden cardiac death. This article evaluates the evidence for a link between psychological vulnerability, ventricular tachyarrhythmias and mortality and the pathways that might explain such a link. This review demonstrates that there is cumulative evidence supporting a link between psychological vulnerability and risk of ventricular tachyarrhythmias and mortality in ICD patients independent of disease severity and other biomedical risk factors. It may be premature to include psychological factors in risk algorithms, but information on the psychological profile of the patient may help to optimize the management and care of these patients in clinical practice.
引用
收藏
页码:377 / 388
页数:12
相关论文
共 50 条
  • [31] Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks
    Sobiech, Marcin
    Lewandowski, Michal
    Zajac, Dariusz
    Maciag, Aleksander
    Syska, Pawel
    Atenska-Pawlowska, Joanna
    Kowalik, Ilona
    Sterlinski, Maciej
    Szwed, Hanna
    Pytkowski, Mariusz
    KARDIOLOGIA POLSKA, 2017, 75 (10) : 1027 - 1032
  • [32] Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator
    Garcia-Moran, E
    Mont, L
    Cuesta, A
    Matas, M
    Brugada, J
    EUROPEAN HEART JOURNAL, 2002, 23 (11) : 901 - 907
  • [33] Ventricular Tachyarrhythmias in Patients Receiving an Implantable Cardioverter-Defibrillator for Primary versus Secondary Prophylaxis Indications
    Manuchehry, Amin
    Agusala, Kartik
    Montevecchi, Mauro
    Kadish, Alan
    Passman, Rod
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (05): : 571 - 576
  • [34] EFFECT OF PROPHYLACTIC ANTIARRHYTHMIC THERAPY ON TIME TO IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR DISCHARGE IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIAS
    ANDERSON, JL
    KARAGOUNIS, LA
    ROSKELLEY, M
    OSBORN, JS
    HANDRAHAN, D
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (09): : 683 - 687
  • [35] Oral mexiletine for ventricular tachyarrhythmias treatment in implantable cardioverter-defibrillator patients: a systematic review of the literature
    Ali, Hussam
    Cristiano, Ernesto
    Lupo, Pierpaolo
    Foresti, Sara
    De Ambroggi, Guido
    De Lucia, Carmine
    Turturiello, Dario
    Paganini, Edoardo M.
    Bessi, Riccardo
    Farghaly, Ahmad A.
    Nicoli, Leoluca
    Cappato, Riccardo
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2023, 71 (06) : 622 - 630
  • [36] Do statins reduce the risk of atrial fibrillation/flutter or ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator?
    Bhavnani, Sanjeev
    Coleman, Craig
    Guertin, Danette
    Zaeem, Faisal
    White, C. Michael
    Yarlagadda, Ravi
    Clyne, Christopher
    Kluger, Jeffrey
    CIRCULATION, 2007, 116 (16) : 728 - 728
  • [37] Psychological distress in patients with an implantable cardioverter defibrillator and their partners
    Rottmann, Nina
    Skov, Ole
    Andersen, Christina Maar
    Theuns, Dominic A. M. J.
    Pedersen, Susanne S.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2018, 113 : 16 - 21
  • [38] Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular Tachyarrhythmias
    Krzowski, Bartosz
    Kutyifa, Valentina
    Vloka, Margot
    Huang, David T.
    Attari, Mehran
    Aktas, Mehmet
    Shah, Abrar H.
    Musat, Dan
    Rosenthal, Lawrance
    McNitt, Scott
    Polonsky, Bronislava
    Schuger, Claudio
    Natale, Andrea
    Ziv, Ohad
    Beck, Christopher
    Daubert, James P.
    Goldenberg, Ilan
    Zareba, Wojciech
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (02) : 284 - 294
  • [39] Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients
    Rusnak, Jonas
    Behnes, Michael
    Reiser, Linda
    Schupp, Tobias
    Bollow, Armin
    Reichelt, Thomas
    Borggrefe, Martin
    Ellguth, Dominik
    Engelke, Niko
    El-Battrawy, Ibrahim
    Ansari, Uzair
    Barre, Max
    Weidner, Kathrin
    Mueller, Julian
    Barth, Christian
    Meininghaus, Dirk Grosse
    Akin, Muharrem
    Bertsch, Thomas
    Taton, Gabriel
    Akin, Ibrahim
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2021, 114 (6-7) : 443 - 454
  • [40] Malignant sustained ventricular tachyarrhythmias in women: Characteristics and outcome of treatment with an implantable cardioverter defibrillator
    Kudenchuk, PJ
    Bardy, GH
    Poole, JE
    Dolack, GL
    Gleva, MJ
    Reddy, R
    Jones, GK
    Troutman, C
    Anderson, J
    Johnson, G
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1997, 8 (01) : 2 - 10